Business

Universal Ibogaine advises of appointment of two new Board Members

(TheNewswire) Calgary, AB – September 3, 2025 – TheNewswire - ...

articleUniversal Ibogaine IncSeptember 3, 20253/company/universal-ibogaine-inc/news/universal-ibogaine-advises-of-appointment-of-two-new-board-members
Universal Ibogaine advises of appointment of two new Board Members

About this update from Universal Ibogaine Inc

[{"type":"text","content":"Universal Ibogaine advises of appointment of two new Board Members\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, AB – September 3, 2025 –\n \n\n TheNewswire -\n \n\n Universal Ibogaine Inc.\n(\n \n\n TSXV:IBO\n \n\n ) (“\n \n\n UI\n \n\n ” or the “\n \n\n Company\n \n\n ”), a life sciences company with a\nmission to research and deliver medicalized ibogaine-centered\naddiction care, advises that the existing Board of Directors of the\nCompany (the “\n \n\n Board\n \n\n ”) appointed two new Directors to join\nthe Board, effective August 28, 2025, with one of the Board members\nfilling a vacant Board position which previously arose in July\n2025.\n \n\n\n\n The two new Board members are Nia Killebrew and Tony\nWagner, who have joined the current Board members Nick Karos (CEO),\nJames Duncan, and Dean Koumontzis.  Bio information for Ms. Killebrew\nand Mr. Wagner are contained in UI’s Management Information Circular\ndated July 23, 2025 (the “\n \n\n Circular\n \n\n ”), which has been provided by UI in\nconnection with the upcoming Annual Meeting of Shareholders (the\n“\n \n\n AGM\n \n\n ”) which is to occur on September 4, 2025.  Mr. Koumontzis\nis not standing for re-election to the Board at the AGM.\n \n\n\n\n A copy of the Circular is available for review on\nSEDAR+ and on the Company’s website.\n \n\n\n\n\n About Universal\nIbogaine Inc.\n \n\n\n\n\n\n UI is a life sciences company,\n \n\n\n\n with a mission to\ntransform addiction treatment using medicalized ibogaine through a\nplanned Canadian clinical trial focused on opioid use disorder, and\nultimately to utilize that treatment protocol globally through planned\nfuture licensing agreements.\n \n\n\n\n UI is concurrently developing a state of the art holistic\naddiction treatment protocol at its Kelburn Recovery Centre (located\nnear Winnipeg, Manitoba) that, which when paired with the planned\nibogaine detox protocol, is intended to revolutionize the way we treat\naddiction and drastically improve the lives of individuals and\nfamilies affected by addiction.\n \n\n\n\n\n\n NEITHER THE TSX\nVENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS\nDEFINED IN THE POLICIES OF TH...

More updates from Universal Ibogaine Inc